These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 19500417

  • 1. Mixed states vs. pure mania in the French sample of the EMBLEM study: results at baseline and 24 months--European mania in bipolar longitudinal evaluation of medication.
    Azorin JM, Aubrun E, Bertsch J, Reed C, Gerard S, Lukasiewicz M.
    BMC Psychiatry; 2009 Jun 07; 9():33. PubMed ID: 19500417
    [Abstract] [Full Text] [Related]

  • 2. [Management of patients with acute manic or mixed episodes and outcome at three months].
    Azorin JM, Luquiens A, Aubrun E, Reed C, Gasquet I, Lukasiewicz M.
    Encephale; 2010 Jun 07; 36(3):226-35. PubMed ID: 20620265
    [Abstract] [Full Text] [Related]

  • 3. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.
    Encephale; 2004 Jun 07; 30(5):417-24. PubMed ID: 15627046
    [Abstract] [Full Text] [Related]

  • 4. Why do clinicians maintain antidepressants in some patients with acute mania? Hints from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM), a large naturalistic study.
    Rosa AR, Cruz N, Franco C, Haro JM, Bertsch J, Reed C, Aarre TF, Sanchez-Moreno J, Vieta E.
    J Clin Psychiatry; 2010 Aug 07; 71(8):1000-6. PubMed ID: 20361912
    [Abstract] [Full Text] [Related]

  • 5. Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM).
    Vieta E, Angst J, Reed C, Bertsch J, Haro JM, EMBLEM advisory board.
    J Affect Disord; 2009 Nov 07; 118(1-3):118-23. PubMed ID: 19269690
    [Abstract] [Full Text] [Related]

  • 6. The management of bipolar mania: a national survey of baseline data from the EMBLEM study in Italy.
    Bellantuono C, Barraco A, Rossi A, Goetz I.
    BMC Psychiatry; 2007 Jul 19; 7():33. PubMed ID: 17640381
    [Abstract] [Full Text] [Related]

  • 7. Olanzapine monotherapy and olanzapine combination therapy in the treatment of mania: 12-week results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) observational study.
    Vieta E, Panicali F, Goetz I, Reed C, Comes M, Tohen M, EMBLEM Advisory Board.
    J Affect Disord; 2008 Feb 19; 106(1-2):63-72. PubMed ID: 17582508
    [Abstract] [Full Text] [Related]

  • 8. Baseline characteristics and outcomes in patients with first episode or multiple episodes of acute mania.
    Tohen M, Vieta E, Gonzalez-Pinto A, Reed C, Lin D, European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) Advisory Board.
    J Clin Psychiatry; 2010 Mar 19; 71(3):255-61. PubMed ID: 19709503
    [Abstract] [Full Text] [Related]

  • 9. Rapid-cycling bipolar I disorder: course and treatment outcome of a large sample across Europe.
    Cruz N, Vieta E, Comes M, Haro JM, Reed C, Bertsch J, EMBLEM Advisory Board.
    J Psychiatr Res; 2008 Oct 19; 42(13):1068-75. PubMed ID: 18262204
    [Abstract] [Full Text] [Related]

  • 10. Mania in the Nordic countries: patients and treatment in the acute phase of the EMBLEM study.
    Larsen JK, Porsdal V, Aarre TF, Koponen HJ, Aarnio J, Kleivenes OK, Emblem Advisory Board.
    Nord J Psychiatry; 2009 Oct 19; 63(4):285-91. PubMed ID: 19140076
    [Abstract] [Full Text] [Related]

  • 11. Clinical and economic consequences of medication non-adherence in the treatment of patients with a manic/mixed episode of bipolar disorder: results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) study.
    Hong J, Reed C, Novick D, Haro JM, Aguado J.
    Psychiatry Res; 2011 Nov 30; 190(1):110-4. PubMed ID: 21571375
    [Abstract] [Full Text] [Related]

  • 12. Effectiveness of olanzapine monotherapy and olanzapine combination treatment in the long term following acute mania--results of a two year observational study in bipolar disorder (EMBLEM).
    Gonzalez-Pinto A, Vieta E, Reed C, Novick D, Barraco A, Aguado J, Haro JM.
    J Affect Disord; 2011 Jun 30; 131(1-3):320-9. PubMed ID: 21195486
    [Abstract] [Full Text] [Related]

  • 13. Evidence for three distinct classes of 'typical', 'psychotic' and 'dual' mania: results from the EMBLEM study.
    Haro JM, van Os J, Vieta E, Reed C, Lorenzo M, Goetz I, EMBLEM Advisory Board.
    Acta Psychiatr Scand; 2006 Feb 30; 113(2):112-20. PubMed ID: 16423162
    [Abstract] [Full Text] [Related]

  • 14. Observational study designs for bipolar disorder - what can they tell us about treatment in acute mania?
    Reed C, Novick D, Gonzalez-Pinto A, Bertsch J, Haro JM.
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun 15; 33(4):715-21. PubMed ID: 19345251
    [Abstract] [Full Text] [Related]

  • 15. The cost-effectiveness of lamotrigine in the maintenance treatment of adults with bipolar I disorder.
    Calvert NW, Burch SP, Fu AZ, Reeves P, Thompson TR.
    J Manag Care Pharm; 2006 May 15; 12(4):322-30. PubMed ID: 16792438
    [Abstract] [Full Text] [Related]

  • 16. Mood stabilizers and antipsychotics for acute mania: a systematic review and meta-analysis of combination/augmentation therapy versus monotherapy.
    Ogawa Y, Tajika A, Takeshima N, Hayasaka Y, Furukawa TA.
    CNS Drugs; 2014 Nov 15; 28(11):989-1003. PubMed ID: 25160685
    [Abstract] [Full Text] [Related]

  • 17. Pharmacological and non-drug treatment of child bipolar I disorder during prospective eight-year follow-up.
    Geller B, Tillman R, Bolhofner K, Zimerman B.
    Bipolar Disord; 2010 Mar 15; 12(2):164-71. PubMed ID: 20402709
    [Abstract] [Full Text] [Related]

  • 18. Treating mixed mania/hypomania: a review and synthesis of the evidence.
    Takeshima M.
    CNS Spectr; 2017 Apr 15; 22(2):177-185. PubMed ID: 28004626
    [Abstract] [Full Text] [Related]

  • 19. Aripiprazole alone or in combination for acute mania.
    Brown R, Taylor MJ, Geddes J.
    Cochrane Database Syst Rev; 2013 Dec 17; 2013(12):CD005000. PubMed ID: 24346956
    [Abstract] [Full Text] [Related]

  • 20. Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety.
    Ghaemi SN, Ostacher MM, El-Mallakh RS, Borrelli D, Baldassano CF, Kelley ME, Filkowski MM, Hennen J, Sachs GS, Goodwin FK, Baldessarini RJ.
    J Clin Psychiatry; 2010 Apr 17; 71(4):372-80. PubMed ID: 20409444
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.